Dr. Joseph M. Jacob, a Urologist and Chief of the Bladder Cancer Program at Upstate Medical University in Syracuse, NY has information about an innovative, non-surgical treatment approach approved by the U.S. Food and Drug Administration (FDA) for patients with Low-grade Upper tract Urothelial Cancer.
